Narnatumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | CD22 |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 1188275-92-4 |
ChemSpider | none |
Chemical and physical data | |
Formula | C6454H10026N1754O2020S44 |
Molar mass | 145.9 kg/mol |
(what is this?) (verify) |
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.[1]
Narnatumab was developed by ImClone Systems.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab" (PDF). American Medical Association.
This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.